Skip to main content
Table of Contents
Print

What Is the Recommended Dosage of Medical Cannabis for CRPS? 

Author: Dr. Clarissa Morton, PharmD

When starting CRPS cannabis therapy, finding the right dose is key, but there’s no one-size-fits-all approach. CRPS varies widely in its severity and how it responds to treatment, so dosage needs to be personalised and closely monitored over time. 

The general principle is to “start low and go slow.” Many patients begin with low doses of CBD, gradually increasing as needed, while THC is introduced cautiously, if at all, depending on tolerance and symptom profile. 

Key Factors in Setting the Right Dose 

Here’s how clinicians typically guide CRPS cannabis therapy and dose recommendations: 

  • Starting small: 
    Patients often begin with a microdose of CBD oil, approximately 5 mg once or twice daily, allowing the body to adjust while watching early shifts in pain response
  • Adjusting gradually 
    THC may be added later, starting at 1 mg or less, especially in cases of severe nerve inflammation or sleep disturbance. 
    Dose adjustments depend on how well symptoms are controlled without causing unwanted side effects. 
  • Tracking and review 
    Regular symptom tracking helps refine the dose. Patients record pain intensity, sleep quality, mobility, and side effects, forming the basis for ongoing adjustments and long-term planning. 
  • Product type and method 
    Vapourised cannabis acts quickly and may be suitable for flare-ups, while oils offer more stable, sustained relief over the day. Product choice impacts how dosing is structured. 

Ultimately, the success of CRPS cannabis therapy comes from collaboration between patient and prescriber and a willingness to adapt based on results. 

Visit providers like LeafEase for expert-led guidance in dosing, tracking, and refining your cannabis treatment for CRPS. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to medical cannabis and Complex Regional Pain Syndrome (CRPS).

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Categories